Clinical Trial Update: Phase IB/II Trial Combining Vinorelbine With Sorafenib as First-Line Treatment in Patients With Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

This update describes a Phase 1/2 trial evaluating the combination of vinorelbine and sorafenib as first-line therapy for metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Nexavar (Sorafenib)
• Vinorelbine (Navelbine) (vinorelbine tartrate)

Snippet

Sponsor: McGill University | Conditions: Metastatic Breast Cancer | Phase 1, Phase 2 | Status: UNKNOWN